HEPCDAC Indication: Daclatasvir is used with another antiviral drug (sofosbuvir) to treat chronic (long-lasting) hepatitis C, a viral infection of the liver.
Daclatasvir should not be used without sofosbuvir.
Daclatasvir and sofosbuvir can be used with another antiviral medicine (ribavirin). These drugs together reduce the amount of hepatitis C virus in your body that helps the immune system fight the infection and can help the liver recover. Chronic hepatitis C can cause serious liver problems such as scarring (cirrhosis) or liver cancer.
Posology and method of administration: Take-daclatasvir exactly as a health care provider says. Do not change the dose if your healthcare provider says it. Do not stop taking daclatasvir without first talking to your healthcare provider. Take 1 hour each day with or without food
The recommended use of daclatasvir for the treatment of chronic hepatitis C infection is 60 mg orally, once daily, with or without food, in combination with sofosbuvir. The recommended duration of treatment is 12 weeks.
Portion 'A' First Floor,
Old No. 131, New No. 50,
Pedariyar Koil Street,
Seven Wells, Chennai - 600001.